Terms: = Thyroid cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Clinical Outcome
49 results:
1. Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
Neyrand S; Trecourt A; Lopez J; Just PA; Descotes F; Borson-Chazot F; Ray-Coquard I; Decaussin-Petrucci M; Devouassoux-Shisheboran M
Histopathology; 2024 Jan; 84(2):291-300. PubMed ID: 37771077
[TBL] [Abstract] [Full Text] [Related]
2. Long-term prognostic analysis of children and adolescents with differentiated thyroid carcinoma based on therapeutic response to initial radioiodine therapy.
Wang C; Lu G; Li Y; Liu X; Wang G; Lu C; Li J; Luo Q; Zhang Q; Sun M; Wang X; Wang R
Front Endocrinol (Lausanne); 2023; 14():1217092. PubMed ID: 37600705
[TBL] [Abstract] [Full Text] [Related]
3. Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expression.
Shi Q; Yu J; Liu D; Ren F; Wu J; Shen K
BMC Cancer; 2023 Feb; 23(1):173. PubMed ID: 36810001
[TBL] [Abstract] [Full Text] [Related]
4. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
5. Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment response.
Kafka M; Burtscher T; Fritz J; Schmitz M; Bektic J; Ladurner M; Horninger W; Heidegger I
World J Urol; 2023 Aug; 41(8):2043-2050. PubMed ID: 36287244
[TBL] [Abstract] [Full Text] [Related]
6. Potential Impact of Body Mass Index on the clinical outcome of Papillary thyroid cancer After High-Dose Radioactive Iodine Therapy.
Cao J; Zhu X; Sun Y; Li X; Yun C; Zhang W
Front Endocrinol (Lausanne); 2022; 13():870530. PubMed ID: 35721759
[TBL] [Abstract] [Full Text] [Related]
7. An Optimal Timing for Removing a Drain After Breast Surgery: A Systematic Review and Meta-Analysis.
Shima H; Kutomi G; Sato K; Kuga Y; Wada A; Satomi F; Uno S; Nisikawa N; Kameshima H; Ohmura T; Mizuguchi T; Takemasa I
J Surg Res; 2021 Nov; 267():267-273. PubMed ID: 34171562
[TBL] [Abstract] [Full Text] [Related]
8. Thyroglobulin Antibodies as a Prognostic Factor in Papillary thyroid Carcinoma Patients with Indeterminate Response After Initial Therapy.
Landenberger GMC; de Souza Salerno ML; Golbert L; de Souza Meyer EL
Horm Metab Res; 2021 Feb; 53(2):94-99. PubMed ID: 32886943
[TBL] [Abstract] [Full Text] [Related]
9. Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients.
Andersen MB; Ebbesen D; Thygesen J; Kruis M; Rasmussen F
Eur Radiol; 2020 Oct; 30(10):5539-5550. PubMed ID: 32367416
[TBL] [Abstract] [Full Text] [Related]
10. Potential Impact of BMI on the Aggressiveness of Presentation and clinical outcome of Differentiated thyroid cancer.
Matrone A; Ceccarini G; Beghini M; Ferrari F; Gambale C; D'Aqui M; Piaggi P; Torregrossa L; Molinaro E; Basolo F; Vitti P; Santini F; Elisei R
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31875910
[TBL] [Abstract] [Full Text] [Related]
11. Ten patients with high-grade transformation of acinic cell carcinomas: Expression profiling of β-catenin and cyclin D1 is useful.
Yue LE; Samankan S; Liu X; Sharif KF; Everest S; Singh T; Dhorajiya P; Baik FM; Khorsandi A; Stevens TM; Brandwein-Weber M; Urken ML
Pathol Res Pract; 2020 Feb; 216(2):152767. PubMed ID: 31812438
[TBL] [Abstract] [Full Text] [Related]
12. Utility of subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance category in ultrasound-guided thyroid fine-needle aspiration in a large referral cancer center.
Gan Q; Edeiken BS; Chen MM; Grubbs EG; Busaidy NL; Zafereo M; Perrier ND; Gule-Monroe MD; Krishnamurthy S
J Am Soc Cytopathol; 2019; 8(6):309-316. PubMed ID: 31526696
[TBL] [Abstract] [Full Text] [Related]
13. Tall Cell Variant of Papillary thyroid Carcinoma: Impact of Change in WHO Definition and Molecular Analysis.
Wong KS; Higgins SE; Marqusee E; Nehs MA; Angell T; Barletta JA
Endocr Pathol; 2019 Mar; 30(1):43-48. PubMed ID: 30565013
[TBL] [Abstract] [Full Text] [Related]
14. Nivolumab-induced thyroid dysfunction in patients with lung cancer.
Ramos-Levi AM; Rogado J; Sanchez-Torres JM; Colomer R; Marazuela M
Endocrinol Diabetes Nutr (Engl Ed); 2019 Jan; 66(1):26-34. PubMed ID: 29910159
[TBL] [Abstract] [Full Text] [Related]
15. The rs2910164 Genetic Variant of miR-146a-3p Is Associated with Increased Overall Mortality in Patients with Follicular Variant Papillary thyroid Carcinoma.
Kotlarek M; Kubiak A; Czetwertyńska M; Świerniak M; Gierlikowski W; Kolanowska M; Bakuła-Zalewska E; Jhiang SM; Jażdżewski K; Wójcicka A
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495389
[TBL] [Abstract] [Full Text] [Related]
16. Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category?
Xu B; Farhat N; Barletta JA; Hung YP; Biase D; Casadei GP; Onenerk AM; Tuttle RM; Roman BR; Katabi N; Nosé V; Sadow P; Tallini G; Faquin WC; Ghossein R
Endocrine; 2018 Jan; 59(1):143-150. PubMed ID: 29204912
[TBL] [Abstract] [Full Text] [Related]
17. Utility of adult-based ultrasound malignancy risk stratifications in pediatric thyroid nodules.
Martinez-Rios C; Daneman A; Bajno L; van der Kaay DCM; Moineddin R; Wasserman JD
Pediatr Radiol; 2018 Jan; 48(1):74-84. PubMed ID: 28983667
[TBL] [Abstract] [Full Text] [Related]
18. Tumor-infiltrating CD45RO
Hu G; Wang S
Sci Rep; 2017 Sep; 7(1):10376. PubMed ID: 28871164
[TBL] [Abstract] [Full Text] [Related]
19. VEGF Trapon inhibits tumor growth in papillary thyroid carcinoma.
Peng XG; Chen ZF; Zhang KJ; Wang PG; Liu ZM; Chen ZJ; Hou GY; Niu M
Eur Rev Med Pharmacol Sci; 2015; 19(2):235-40. PubMed ID: 25683936
[TBL] [Abstract] [Full Text] [Related]
20. Local recurrence in the neck and survival after thyroidectomy for metastatic renal cell carcinoma.
Iesalnieks I; Machens A; Bures C; Krenz D; Winter H; Vorländer C; Bareck E; Alesina PF; Musholt T; Steinmüller T; Anthuber M; Goretzki P; Trupka A; Mayr M; Weber T; Schlitt HJ; Dralle H; Hermann M; Agha A
Ann Surg Oncol; 2015; 22(6):1798-805. PubMed ID: 25472649
[TBL] [Abstract] [Full Text] [Related]
[Next]
